E-therapeutics (ETX)

Company name:E-therapeutics Plc
EPIC:ETXTrading Currency:GBX
Market Sector:AIMPISIN:GB00B2823H99
Market Segment:ASX1Share Type:DE
WWW Address:http://www.etherapeutics.co.uk/Description:ORD 0.1P
 Price Price Change [%] Bid Offer Open High Low Volume
 3.34 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 3.28 3.40 3.34 3.34 3.34 42,321
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 8.96 268.39 -0.02 -1.49 - - - 6.85 - 1.43

E-therapeutics Key Figures

(at previous day's close)
Market Cap.8.96m
Shares In Issue268.39m
Prev. Close3.34
PE Ratio- 
Dividend Yield-%
EPS - basic-1.49p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-1.38p
Return On Equity (ROE)-58.79%
Operating Margin-11,556.82%
PEG Factor- 
EPS Growth Rate25.50%
Dividends PS Growth Rate-%
Net Debt-5.20m
Gross Gearing9.42%
Quick Assets7.35m
Net Working Capital6.64m
Intangibles / Fixed Assets73.91%
Turnover PS0.02p
Pre-Tax Profit PS-1.89p
Retained Profit PS-1.49p
Cash PS2.20p
Net Cash PS1.94p
Net Tangible Asset Value PS *2.49p
Net Asset Value PS2.53p
Spread0.12 (3.53%) 

E-therapeutics Balance Sheet


Share Price Performance

Sample Period HighLow
1 week3.403.25
4 weeks3.403.00
12 weeks4.102.40
1 year6.851.43

Share Price Chart (5 years)

E-therapeutics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week3.250.092.773.250.633.29
4 weeks3.170.175.363.001.383.14
12 weeks4.00-0.66-16.502.404.082.66
26 weeks1.851.4980.541.435.522.72
1 year6.75-3.41-50.521.433.502.73
3 years8.38-5.04-60.121.431.724.19
5 years28.50-25.16-88.281.431.034.93

E-therapeutics Key Management Ratios

E-therapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.93 
Tobin's Q Ratio (excl. intangibles)0.94 
Dividend Yield-%
Market-to-Book Ratio1.32 
Price-to-Pre-Tax Profit PS-1.76 
Price-to-Retained Profit PS-2.24 
Price-to-Cash Flow PS-2.42 
Price-to-Sales PS203.73 
Price-to-Net Tangible Asset Value PS1.34 
Price-to-Cash PS1.52 
Net Working Capital PS2.47 
Price Pct to Working Capital PS1.35%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

E-therapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-69.21%
Net Gearing (excl. Intangibles)-70.32%
Gross Gearing9.42%
Gross Gearing (excl. Intangibles)9.57%
Gearing Under 1 Year9.42%
Gearing Under 1 Year (excl. Intgbl)9.57%
(Liquidity Ratios)
Net Working Capital to Total Assets88.44%
Current Ratio10.39 
Quick Ratio (Acid Test)10.39 
Liquidity Ratio8.35 
Cash & Equiv/Current Assets80.35%
(Solvency Ratios)
Enterprise Value3.06m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.08 
Total Debt/Sales16.07 
Total Debt/Pre-Tax Profit-0.14 
Total Debt0.71m
Total Debt/Net Current Assets0.11%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-32.80%
5 yr Compound Earnings Growth-12.71%
10 yr Compound Earnings Growth-6.63%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)

E-therapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-74.76%
Return On Assets (ROA)-41.50%
Net Profit Margin-9,088.64%
Assets Turnover0.00 
Return On Equity (ROE)-58.79%
Return On Investment (ROI)-45.60%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-9,088.64%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.01 
Fixed Assets Turnover0.24 
Current Assets Turnover0.00 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales218.99 
Debt Collection Period14,114.72Days

E-therapeutics Dividends

Sorry No Data Available

E-therapeutics Fundamentals

 31 Jan 2016 (GBP)31 Jan 2017 (GBP)31 Jan 2018 (GBP)31 Jan 2019 (GBP)
pre tax profit-11.28--16.20--6.72--5.09-m
attributable profit-8.82--13.13--5.36--4.00-m
retained profit-8.82--13.13--5.36--4.00-m
eps - basic (p)-3.34 -4.91 -2.00 -1.49 
eps - diluted (p)-3.34 -4.91 -2.00 -1.49 
dividends per share- - - - 

E-therapeutics Balance Sheet

 31 Jan 2016 (GBP)31 Jan 2017 (GBP)31 Jan 2018 (GBP)31 Jan 2019 (GBP)
 31 Jan 2016 (GBP)31 Jan 2017 (GBP)31 Jan 2018 (GBP)31 Jan 2019 (GBP)
fixed assets fixed assets0.060.22%0.050.28%0.070.60%0.040.56%m
intangibles intangibles0.742.50%0.160.87%0.141.15%0.121.58%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other18.5062.53%9.5052.98%2.5021.25%--%m
stocks stocks--%--%--%--%m
debtors debtors3.9413.32%3.7520.91%1.9616.66%1.4419.23%m
cash & securities cash & securities6.3421.44%4.4824.96%7.1060.34%5.9078.63%m
creditors - short creditors - short1.163.91%1.9510.88%1.028.71%0.719.42%m
creditors - long creditors - long--%--%--%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves28.4396.09%15.9889.12%10.7491.29%6.8090.58%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

E-therapeutics Cash Flow Statement

31 Jan 2016 (GBP)31 Jan 2017 (GBP)31 Jan 2018 (GBP)31 Jan 2019 (GBP)
Operating CF-9.18-9.44-4.41-3.70m
Pre-Financing CF4.51-1.882.61-1.20m
Retained CF4.52-1.872.62-1.19m

E-therapeutics Brokers

Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191212 09:33:17